Glaxosmithkline Investment Holdings Limited

Company Name	Glaxosmithkline Investment Holdings Limited
Company Status	Dissolved
Company Number	07089743
Category	Private Limited Company
Incorporation Date	27 November 2009(14 years, 5 months ago)
Dissolution Date	18 April 2022 (2 years ago)

Business Activity

Section M	Professional, scientific and technical activities
SIC 7415	Holding Companies including Head Offices
SIC 70100	Activities of head offices

Directors

Director Name	Ms Sarah Ghinn
Date of Birth	August 1963 (Born 60 years ago)
Nationality	British
Status	Closed
Appointed	07 August 2020(10 years, 8 months after company formation)
Appointment Duration	1 year, 8 months (closed 18 April 2022)
Role	Company Director
Country of Residence	England
Correspondence Address	55 Baker Street London W1U 7EU

Director Name	Mr John Michael Sadler
Date of Birth	March 1956 (Born 68 years ago)
Nationality	British
Status	Closed
Appointed	07 August 2020(10 years, 8 months after company formation)
Appointment Duration	1 year, 8 months (closed 18 April 2022)
Role	Company Director
Country of Residence	England
Correspondence Address	55 Baker Street London W1U 7EU

Secretary Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Closed
Appointed	27 November 2009(same day as company formation)
Correspondence Address	Shewalton Road Shewalton Road Irvine Ayrshire KA11 5AP Scotland

Director Name	Mr Paul Frederick Blackburn
Date of Birth	October 1954 (Born 69 years ago)
Nationality	British
Status	Resigned
Appointed	27 November 2009(same day as company formation)
Role	Accountant
Country of Residence	England
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Mr Adam Walker
Date of Birth	November 1967 (Born 56 years ago)
Nationality	British
Status	Resigned
Appointed	30 April 2015(5 years, 5 months after company formation)
Appointment Duration	5 years, 3 months (resigned 07 August 2020)
Role	Company Director
Country of Residence	United Kingdom
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Director Name	Edinburgh Pharmaceutical Industries Limited (Corporation)
Status	Resigned
Appointed	27 November 2009(same day as company formation)
Correspondence Address	Shewalton Road Shewalton Road Irvine Ayrshire KA11 5AP Scotland

Director Name	Glaxo Group Limited (Corporation)
Status	Resigned
Appointed	27 November 2009(same day as company formation)
Correspondence Address	980 Great West Road Brentford Middlesex TW8 9GS

Contact

Website	gsk.com
Telephone	020 80475000
Telephone region	London

Location

Registered Address	Bdo Llp 55 Baker Street London W1U 7EU
Region	London
Constituency	Cities of London and Westminster
County	Greater London
Ward	Marylebone High Street
Built Up Area	Greater London
Address Matches	9 other UK companies use this postal address

Shareholders

2.5b at £1	Setfirst LTD 100.00% Ordinary

Financials

Year	2014
Net Worth	£2,147,483,647
Current Liabilities	£10,156,000

Accounts

Latest Accounts	31 December 2019 (4 years, 3 months ago)
Accounts Category	Total Exemption Full
Accounts Year End	31 December

Filing History

18 April 2022	Final Gazette dissolved following liquidation (1 page)
18 January 2022	Return of final meeting in a members' voluntary winding up (24 pages)
20 October 2021	Liquidators' statement of receipts and payments to 7 October 2021 (15 pages)
5 December 2020	Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS to 55 Baker Street London W1U 7EU on 5 December 2020 (2 pages)
29 October 2020	Resolutions LRESSP ‐ Special resolution to wind up on 2020-10-08 (1 page)
28 October 2020	Appointment of a voluntary liquidator (3 pages)
28 October 2020	Declaration of solvency (5 pages)
7 September 2020	Total exemption full accounts made up to 31 December 2019 (15 pages)
14 August 2020	Appointment of Sarah Ghinn as a director on 7 August 2020 (2 pages)
14 August 2020	Termination of appointment of Adam Walker as a director on 7 August 2020 (1 page)
14 August 2020	Termination of appointment of Glaxo Group Limited as a director on 7 August 2020 (1 page)
14 August 2020	Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 7 August 2020 (1 page)
14 August 2020	Appointment of Mr John Sadler as a director on 7 August 2020 (2 pages)
1 June 2020	Consolidated accounts of parent company for subsidiary company period ending 31/12/19 (316 pages)
20 February 2020	Notice of agreement to exemption from audit of accounts for period ending 31/12/19 (1 page)
20 February 2020	Audit exemption statement of guarantee by parent company for period ending 31/12/19 (3 pages)
16 December 2019	Confirmation statement made on 27 November 2019 with updates (4 pages)
11 September 2019	Full accounts made up to 31 December 2018 (15 pages)
8 January 2019	Confirmation statement made on 27 November 2018 with updates (4 pages)
12 July 2018	Full accounts made up to 31 December 2017 (16 pages)
30 November 2017	Confirmation statement made on 27 November 2017 with updates (4 pages)
30 November 2017	Confirmation statement made on 27 November 2017 with updates (4 pages)
14 August 2017	Full accounts made up to 31 December 2016 (14 pages)
14 August 2017	Full accounts made up to 31 December 2016 (14 pages)
28 November 2016	Confirmation statement made on 27 November 2016 with updates (5 pages)
28 November 2016	Confirmation statement made on 27 November 2016 with updates (5 pages)
17 June 2016	Full accounts made up to 31 December 2015 (14 pages)
17 June 2016	Full accounts made up to 31 December 2015 (14 pages)
1 March 2016	Termination of appointment of Paul Frederick Blackburn as a director on 1 March 2016 (1 page)
1 March 2016	Termination of appointment of Paul Frederick Blackburn as a director on 1 March 2016 (1 page)
14 December 2015	Annual return made up to 27 November 2015 with a full list of shareholders Statement of capital on 2015-12-14 GBP 2,547,000,100 (6 pages)
14 December 2015	Annual return made up to 27 November 2015 with a full list of shareholders Statement of capital on 2015-12-14 GBP 2,547,000,100 (6 pages)
1 May 2015	Appointment of Mr Adam Walker as a director on 30 April 2015 (2 pages)
1 May 2015	Appointment of Mr Adam Walker as a director on 30 April 2015 (2 pages)
15 April 2015	Full accounts made up to 31 December 2014 (11 pages)
15 April 2015	Full accounts made up to 31 December 2014 (11 pages)
10 December 2014	Annual return made up to 27 November 2014 with a full list of shareholders Statement of capital on 2014-12-10 GBP 2,547,000,100 (5 pages)
10 December 2014	Annual return made up to 27 November 2014 with a full list of shareholders Statement of capital on 2014-12-10 GBP 2,547,000,100 (5 pages)
9 December 2014	Director's details changed for Edinburgh Pharmaceutical Industries Limited on 27 November 2009 (1 page)
9 December 2014	Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 27 November 2009 (1 page)
9 December 2014	Director's details changed for Edinburgh Pharmaceutical Industries Limited on 27 November 2009 (1 page)
9 December 2014	Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 27 November 2009 (1 page)
10 April 2014	Full accounts made up to 31 December 2013 (11 pages)
10 April 2014	Full accounts made up to 31 December 2013 (11 pages)
13 December 2013	Annual return made up to 27 November 2013 with a full list of shareholders Statement of capital on 2013-12-13 GBP 2,547,000,100 (5 pages)
13 December 2013	Annual return made up to 27 November 2013 with a full list of shareholders Statement of capital on 2013-12-13 GBP 2,547,000,100 (5 pages)
22 April 2013	Full accounts made up to 31 December 2012 (10 pages)
22 April 2013	Full accounts made up to 31 December 2012 (10 pages)
12 December 2012	Annual return made up to 27 November 2012 with a full list of shareholders (5 pages)
12 December 2012	Annual return made up to 27 November 2012 with a full list of shareholders (5 pages)
29 August 2012	Full accounts made up to 31 December 2011 (10 pages)
29 August 2012	Full accounts made up to 31 December 2011 (10 pages)
20 December 2011	Annual return made up to 27 November 2011 with a full list of shareholders (5 pages)
20 December 2011	Annual return made up to 27 November 2011 with a full list of shareholders (5 pages)
1 December 2011	Solvency statement dated 01/12/11 (2 pages)
1 December 2011	Resolutions RES06 ‐ Resolution of reduction in issued share capital (1 page)
1 December 2011	Statement of capital on 1 December 2011 GBP 254.70 (4 pages)
1 December 2011	Statement by directors (2 pages)
1 December 2011	Statement of capital on 1 December 2011 GBP 254.70 (4 pages)
1 December 2011	Statement by directors (2 pages)
1 December 2011	Statement of capital on 1 December 2011 GBP 254.70 (4 pages)
1 December 2011	Resolutions RES06 ‐ Resolution of reduction in issued share capital (1 page)
1 December 2011	Solvency statement dated 01/12/11 (2 pages)
14 April 2011	Full accounts made up to 31 December 2010 (10 pages)
14 April 2011	Full accounts made up to 31 December 2010 (10 pages)
20 December 2010	Annual return made up to 27 November 2010 with a full list of shareholders (15 pages)
20 December 2010	Annual return made up to 27 November 2010 with a full list of shareholders (15 pages)
21 January 2010	Statement of capital following an allotment of shares on 18 January 2010 GBP 2,547,000,100 (4 pages)
21 January 2010	Current accounting period extended from 30 November 2010 to 31 December 2010 (2 pages)
21 January 2010	Statement of capital following an allotment of shares on 18 January 2010 GBP 2,547,000,100 (4 pages)
21 January 2010	Current accounting period extended from 30 November 2010 to 31 December 2010 (2 pages)
27 November 2009	Incorporation (50 pages)
27 November 2009	Incorporation (50 pages)

Glaxosmithkline Investment Holdings Limited

Business Activity

Directors

Contact

Location

Shareholders

Financials

Accounts

Filing History

Contact Companies London